JC-Virus (JCV) Antibody Program

计划入组 1,096 人 · 首次发布于 2010 年 2 月 18 日

JC Virus Reactivation in Multiple Sclerosis

计划入组 50 人 · 首次发布于 2013 年 12 月 9 日

JC-virus (JCV) Epidemiology in Multiple Sclerosis (MS)

计划入组 7,726 人 · 首次发布于 2010 年 8 月 20 日

JC virus infection therapeutics (Hybridize Therapeutics)

CE-VST01-JC

JC-229

JC MEDICAL, INC.

United States

Assembly Biosciences

United States

AbbVie CDR (CAD Hedged)

United States

First European Real-World Analysis Validates ImmunoWELL JCV Test for PML Risk Assessment in Multiple Sclerosis Patients

Experimental Off-the-Shelf T Cell Therapy Achieves 56.8% Response Rate in Rare, Often Fatal Brain Infection

FTC Blocks Edwards Lifesciences' $945M JenaValve Acquisition Over TAVR-AR Device Competition Concerns